Home » Stocks » MediWound

MediWound Ltd. (MDWD)

Stock Price: $3.36 USD -0.22 (-6.15%)
Updated Aug 12, 2020 1:11 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 91.43M
Revenue (ttm) 19.05M
Net Income (ttm) 4.96M
Shares Out 27.21M
EPS (ttm) -0.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $3.36
Previous Close $3.58
Change ($) -0.22
Change (%) -6.15%
Day's Open 3.60
Day's Range 3.34 - 3.65
Day's Volume 116,927
52-Week Range 1.44 - 4.44

More Stats

Market Cap 91.43M
Enterprise Value 64.73M
Earnings Date (est) Nov 12, 2020
Ex-Dividend Date n/a
Shares Outstanding 27.21M
Float 17.12M
EPS (basic) 0.18
EPS (diluted) -0.34
FCF / Share 0.28
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 8.20%
Payout Ratio n/a
Shares Short 41,948
Short Ratio 0.65
Short % of Float 0.83%
Beta 1.63
PE Ratio n/a
Forward PE n/a
P/FCF Ratio 12.20
PS Ratio 4.80
PB Ratio 9.61
Revenue 19.05M
Operating Income 4.49M
Net Income 4.96M
Free Cash Flow 7.50M
Net Cash 26.70M
Net Cash / Share 0.98
Gross Margin 104.69%
Operating Margin 23.59%
Profit Margin 15.60%
FCF Margin 39.36%
ROA -14.21%
ROE -85.11%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$6.62*
(97.02% upside)
Low
5.50
Current: $3.36
High
7.00
Target: 6.62
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014201320122011
Revenue31.793.402.501.560.600.26---
Revenue Growth834.7%36.26%60.21%159.23%132.05%----
Gross Profit19.941.310.92-0.60-1.92-2.53---
Operating Income4.49-3.96-13.69-20.16-21.23-21.43-7.58-2.73-4.29
Net Income4.96-1.06-22.15-18.89-22.09-18.88-15.3510.94-6.17
Shares Outstanding27.1827.0521.9321.8521.5520.4020.40--
Earnings Per Share0.18-0.04-0.95-0.86-1.02-0.95-0.980.64-0.39
Operating Cash Flow8.29-12.15-16.46-16.45-19.60-16.49-9.74-4.73-2.96
Capital Expenditures-0.79-0.52-1.05-0.67-0.38-0.37-0.27-0.06-0.76
Free Cash Flow7.50-12.68-17.50-17.12-19.98-16.86-10.01-4.79-3.72
Cash & Equivalents29.2823.5436.0730.0345.7764.859.550.340.00
Total Debt2.580.15-----1.56-
Net Cash / Debt26.7023.4036.0730.0345.7764.859.55-1.220.00
Assets40.5935.2844.1435.7652.5271.1214.8325.44-
Liabilities25.4226.3034.5227.9929.0528.2534.639.80-
Book Value15.178.979.627.7723.4742.87-19.8015.63-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name MediWound Ltd.
Country Israel
Employees 74
CEO Sharon Malka

Stock Information

Ticker Symbol MDWD
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: MDWD
IPO Date March 20, 2014

Description

MediWound Ltd., an integrated biopharmaceutical company, focuses on developing, manufacturing, and commercializing novel therapeutics products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; and MWPC003 for connective tissue disorders. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.